C Hua1, B Combe2. 1. Rheumatology Department, Lapeyronie Hospital, Montpellier University, CHU Lapeyronie-191 Av. du Doyen Gaston Giraud, 34295, cedex 5, Montpellier, France. c-hua@chu-montpellier.fr. 2. Rheumatology Department, Lapeyronie Hospital, Montpellier University, CHU Lapeyronie-191 Av. du Doyen Gaston Giraud, 34295, cedex 5, Montpellier, France.
Abstract
PURPOSE OF REVIEW: Chikungunya virus (CHIKV) infection has become increasingly prevalent in the last decade not only across the southern hemisphere but also, because of a recently documented viral mutation, in southern Europe and the USA. With the global spread of CHIKV infection, practitioners should know its epidemiology, pathophysiology and clinical features. RECENT FINDINGS: The acute phase of CHIKV disease is characterised by a fever-arthralgia-rash syndrome. Chronic rheumatic manifestations can persist for months to years with very variable clinical presentations. Some cases mimic inflammatory rheumatism such as rheumatoid arthritis. Several risk factors for persistent joint pain, notably older age, have been identified in cohort studies. Despite a low mortality rate with CHIKV infection, the rate of disability with chronic joint symptoms is high, and effective treatments are lacking. Current research is focusing on the development of vaccines and antiviral drugs, and data on treatment of CHIKV-induced chronic arthritis are needed.
PURPOSE OF REVIEW: Chikungunya virus (CHIKV) infection has become increasingly prevalent in the last decade not only across the southern hemisphere but also, because of a recently documented viral mutation, in southern Europe and the USA. With the global spread of CHIKV infection, practitioners should know its epidemiology, pathophysiology and clinical features. RECENT FINDINGS: The acute phase of CHIKV disease is characterised by a fever-arthralgia-rash syndrome. Chronic rheumatic manifestations can persist for months to years with very variable clinical presentations. Some cases mimic inflammatory rheumatism such as rheumatoid arthritis. Several risk factors for persistent joint pain, notably older age, have been identified in cohort studies. Despite a low mortality rate with CHIKV infection, the rate of disability with chronic joint symptoms is high, and effective treatments are lacking. Current research is focusing on the development of vaccines and antiviral drugs, and data on treatment of CHIKV-induced chronic arthritis are needed.
Authors: F Simon; E Javelle; A Cabie; E Bouquillard; O Troisgros; G Gentile; I Leparc-Goffart; B Hoen; F Gandjbakhch; P Rene-Corail; J-M Franco; E Caumes; B Combe; S Poiraudeau; F Gane-Troplent; F Djossou; T Schaerverbeke; A Criquet-Hayot; P Carrere; D Malvy; P Gaillard; D Wendling Journal: Med Mal Infect Date: 2015-06-25 Impact factor: 2.152
Authors: Teck-Hui Teo; Fok-Moon Lum; Carla Claser; Valeria Lulla; Aleksei Lulla; Andres Merits; Laurent Rénia; Lisa F P Ng Journal: J Immunol Date: 2012-12-03 Impact factor: 5.422
Authors: Angelica Cifuentes Kottkamp; Elfie De Jesus; Rebecca Grande; Julia A Brown; Adam R Jacobs; Jean K Lim; Kenneth A Stapleford Journal: J Virol Date: 2019-05-15 Impact factor: 5.103
Authors: Grace L Chen; Emily E Coates; Sarah H Plummer; Cristina A Carter; Nina Berkowitz; Michelle Conan-Cibotti; Josephine H Cox; Allison Beck; Mark O'Callahan; Charla Andrews; Ingelise J Gordon; Brenda Larkin; Rebecca Lampley; Florence Kaltovich; Jason Gall; Kevin Carlton; Jason Mendy; Doug Haney; Jeanine May; Amy Bray; Robert T Bailer; Kimberly A Dowd; Brittanie Brockett; David Gordon; Richard A Koup; Richard Schwartz; John R Mascola; Barney S Graham; Theodore C Pierson; Yeycy Donastorg; Nicolas Rosario; Jean William Pape; Bruno Hoen; André Cabié; Clemente Diaz; Julie E Ledgerwood Journal: JAMA Date: 2020-04-14 Impact factor: 56.272
Authors: Thomas C McHale; Claudia M Romero-Vivas; Claudio Fronterre; Pedro Arango-Padilla; Naomi R Waterlow; Chad D Nix; Andrew K Falconar; Jorge Cano Journal: Int J Environ Res Public Health Date: 2019-05-18 Impact factor: 3.390
Authors: José V J Silva; Louisa F Ludwig-Begall; Edmilson F de Oliveira-Filho; Renato A S Oliveira; Ricardo Durães-Carvalho; Thaísa R R Lopes; Daisy E A Silva; Laura H V G Gil Journal: Acta Trop Date: 2018-09-06 Impact factor: 3.112
Authors: Maira Sant Anna Genaro; Micheli Said de Marchi; Matheus Yung Perin; Isabelle Silva Cossô; Renata Dezengrini Slhessarenko Journal: Am J Trop Med Hyg Date: 2020-11 Impact factor: 2.345
Authors: Juarez P Dias; Maria da Conceição N Costa; Gubio Soares Campos; Enny S Paixão; Marcio S Natividade; Florisneide R Barreto; Martha Suely C Itaparica; Cristina Goes; Francisca L S Oliveira; Eloisa B Santana; Neusa S J Silva; Carlos A A Brito; Laura C Rodrigues; Silvia Inez Sardi; Ramon C Saavedra; Maria Glória Teixeira Journal: Emerg Infect Dis Date: 2018-04 Impact factor: 6.883
Authors: Brianne M Hibl; Natalie J M Dailey Garnes; Alexander R Kneubehl; Megan B Vogt; Jennifer L Spencer Clinton; Rebecca R Rico-Hesse Journal: PLoS Negl Trop Dis Date: 2021-06-09